Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.